Pharmanetics/Aventis: agreement to develop theranostic test for enoxaparin
Article Abstract:
Raleigh, NC-based PharmaNetics Inc. has signed a letter of intent with Bridgewater, NJ-based Aventis Pharmaceuticals to develop and supply a new theranostic test to use with Aventis Pharmaceuticals' low-molecular weight heparin Enoxaparin.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
JInfectious disease: FDA expanded review: Roche Molecular Systems
Article Abstract:
Pleasanton, CA-based Roche Molecular Systems Inc. has received FDA premarket approval and been granted expedited review for two hepatitis C tests intended to directly detect the hepatitis C virus in the blood.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Adventist branding campaign promises to keep patients well and well informed. Denver hospital campaign targets people who should be wearing helmets
- Abstracts: The effects of Medicaid expansions and reimbursement increases on dentists' participation. Medicaid expansions and the crowding out of private health insurance among children
- Abstracts: The Impact of Risk Shifting and Contracting on Mental Health Service Costs in California. Health policy in the Land of Oz
- Abstracts: Breast cancer treatment choice and mastectomy length of stay: a comparison of HMO and other privately insured women
- Abstracts: Medicine and Applications: Matritech: encouraging results for NMP 66 test. Cancer: Biosafe: prostate cancer awareness program